All Updates

All Updates

icon
Filter
Partnerships
Ontada partners with Datavant to enhance access to oncology real-world data
Clinical Trial Technology
Nov 12, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Clinical Trial Technology

Clinical Trial Technology

Nov 12, 2024

Ontada partners with Datavant to enhance access to oncology real-world data

Partnerships

  • Ontada, a McKesson business specializing in oncology real-world data, partnered with health data platform Datavant to improve access to oncology research data.

  • Through this partnership, life science companies will gain faster access to Ontada's comprehensive real-world data covering 2.4 million patients across 80+ tumor types. The collaboration enables researchers to connect Ontada's data with other datasets through Datavant's secure health data ecosystem, accelerating oncology innovation and drug development.

  • The partnership leverages Ontada's data from The US Oncology Network, which treats one in five cancer patients in the US, providing researchers with insights into community cancer care for the development of new cancer therapies and care delivery models.

  • Analyst Quicktake: This marks the second partnership agreement Ontada signed this year. Earlier, in October , Ontada partnered with Microsoft to use Azure AI to process unstructured oncology data. By partnering with Datavant, it appears Ontada is adopting a strategy of expanding its platform's capabilities and market reach through partnerships.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.